• CAR T-cell therapy may be effective for colorectal cancer

    2 monthes ago - By Healio

    Adam Snook
    Chimeric antigen receptor T-cell therapy may be an effective treatment strategy for colorectal cancer, according to study results.
    Adam Snook, PhD, assistant professor in the department of pharmacology and experimental therapeutics at Thomas Jefferson University, and colleagues observed the efficacy of CAR T-cell therapy for treating tumors and preventing metastases among mice. These findings laid the groundwork for a trial designed to assess the approach among humans.
    “The antigen we target for colorectal cancer is one that is shared across several high-mortality cancers,
    Read more ...